- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ovid Therapeutics Inc (OVID)
Ovid Therapeutics Inc stock price live, this page displays NASDAQ OVID stock exchange data. View the OVID premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ovid Therapeutics Inc real time stock price chart below.
What Is the Ovid Therapeutics Inc Stock Price Today?
The Ovid Therapeutics Inc stock price today is 2.795.
What Is the Stock Symbol for Ovid Therapeutics Inc?
The stock ticker symbol for Ovid Therapeutics Inc is OVID.
Is OVID the Same as $OVID?
$OVID is a common way to refer to the Ovid Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Ovid Therapeutics Inc Trade On?
Ovid Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Ovid Therapeutics Inc a Good Stock to Buy?
Determining whether Ovid Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Ovid Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OVID quote. (ISIN: US6904691010)
What Is the Ovid Therapeutics Inc Stock Price Today?
The Ovid Therapeutics Inc stock price today is 2.795.
What Is the Stock Symbol for Ovid Therapeutics Inc?
The stock ticker symbol for Ovid Therapeutics Inc is OVID.
Is OVID the Same as $OVID?
$OVID is a common way to refer to the Ovid Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Ovid Therapeutics Inc Trade On?
Ovid Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Ovid Therapeutics Inc a Good Stock to Buy?
Determining whether Ovid Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Ovid Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OVID quote. (ISIN: US6904691010)
2.795
+0.055(+2.01%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.710
2.830
52 wk Range
0.940
3.105
OVID is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.7102.830
52 wk Range
0.9403.105
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OVID Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
5.693
Upside
+103.70%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
Form 8K Ovid Therapeutics Inc For: 13 August- Investing.com
Form 4 Ovid Therapeutics Inc For: 8 July- Investing.com
- Form 8K Ovid Therapeutics Inc For: 13 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Analyst Ratings
10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 5.693
(+103.70% Upside)
Ovid Therapeutics Inc Earnings Call Summary for Q4/2025
- Ovid Therapeutics reported Q4 2025 EPS of $0.06 vs. forecast of -$0.1137, beating expectations by 152.77%; revenue hit $718K vs. $80.7K forecast.
- Stock surged 19.91% pre-market to $2.41, trading near 52-week high with market cap of $311M and impressive 337% one-year return.
- Company secured strategic financing extending cash runway into H2 2028, with $90.4M in cash equivalents and marketable securities as of Dec 31.
- Positive clinical data for OV329 demonstrated differentiated safety profile; CEO emphasized commitment to advancing pipeline and innovative treatments.
- Despite earnings beat, analysts forecast continued losses with price targets ranging $2-$7; company maintains strong liquidity with 4.24 current ratio.
Last Updated: 03/18/2026, 10:01 AM
Read Full TranscriptOvid Therapeutics investor slides for Q4/2025
Last Update: Mar 18, 2026
See full investor slides
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
-0.08 / -0.12
Revenue / Forecast
733K / 56.25K
Compare OVID to Peers and Sector
Metrics to compare | OVID | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOVIDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.8x | −1.8x | −0.3x | |
PEG Ratio | −0.33 | −0.03 | 0.00 | |
Price / Book | 2.6x | 2.7x | 2.6x | |
Price / LTM Sales | 344.8x | 75.2x | 3.1x | |
Upside (Analyst Target) | 82.5% | 110.6% | 47.6% | |
Fair Value Upside | Unlock | 11.1% | 5.6% | Unlock |
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ovid Therapeutics (OVID) Stock Price Today?
The Ovid Therapeutics stock price today is 2.795 USD.
What Stock Exchange Does Ovid Therapeutics Trade On?
Ovid Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Ovid Therapeutics?
The stock symbol for Ovid Therapeutics is "OVID."
What Is the Ovid Therapeutics Market Cap?
As of today, Ovid Therapeutics market cap is 545.860M USD.
What Is Ovid Therapeutics's Earnings Per Share (TTM)?
The Ovid Therapeutics EPS (TTM) is -0.284.
When Is the Next Ovid Therapeutics Earnings Date?
Ovid Therapeutics will release its next earnings report on Nov 11, 2026.
From a Technical Analysis Perspective, Is OVID a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Ovid Therapeutics Stock Split?
Ovid Therapeutics has split 0 times.
How Many Employees Does Ovid Therapeutics Have?
Ovid Therapeutics has 23 employees.
What is the current trading status of Ovid Therapeutics (OVID)?
As of Aug 21, 2026, Ovid Therapeutics (OVID) is trading at a price of 2.795 USD, with a previous close of 2.740 USD. The stock has fluctuated within a day range of 2.710 USD to 2.830 USD, while its 52-week range spans from 0.940 USD to 3.105 USD.
What Is Ovid Therapeutics (OVID) Price Target According to Analysts?
The average 12-month price target for Ovid Therapeutics is 5.693 USD, with a high estimate of 9 USD and a low estimate of 4 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +103.70% Upside potential.
What Is the OVID Premarket Price?
OVID's last pre-market stock price is 2.900 USD. The pre-market share volume is 240.000, and the stock has decreased by 0.160, or 5.840%.
What Is the OVID After Hours Price?
OVID's last after hours stock price is 2.820 USD, the stock has decreased by 0.080, or 2.920%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.